← Evidence map

ArticleGenes2025

Clinical Significance of Fragile X Syndrome 2 (FXR2) in Breast Cancer.

Ohud A Alsalmi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 40149453